Abivax Socit Anonyme Stock Price Prediction
AAVXF Stock | USD 11.05 0.00 0.00% |
Oversold Vs Overbought
0
Oversold | Overbought |
Using ABIVAX Société hype-based prediction, you can estimate the value of ABIVAX Socit Anonyme from the perspective of ABIVAX Société response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in ABIVAX Société to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying ABIVAX because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
ABIVAX Société after-hype prediction price | USD 11.05 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
ABIVAX |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ABIVAX Société's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ABIVAX Société After-Hype Price Prediction Density Analysis
As far as predicting the price of ABIVAX Société at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ABIVAX Société or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of ABIVAX Société, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
ABIVAX Société Estimiated After-Hype Price Volatility
In the context of predicting ABIVAX Société's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ABIVAX Société's historical news coverage. ABIVAX Société's after-hype downside and upside margins for the prediction period are 11.05 and 11.05, respectively. We have considered ABIVAX Société's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ABIVAX Société is very steady at this time. Analysis and calculation of next after-hype price of ABIVAX Socit Anonyme is based on 3 months time horizon.
ABIVAX Société Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as ABIVAX Société is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ABIVAX Société backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ABIVAX Société, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 2 Events / Month | In 5 to 10 days |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
11.05 | 11.05 | 0.00 |
|
ABIVAX Société Hype Timeline
ABIVAX Socit Anonyme is presently traded for 11.05. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. ABIVAX is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at 0.0%. %. The volatility of related hype on ABIVAX Société is about 0.0%, with the expected price after the next announcement by competition of 11.05. About 57.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 2.59. ABIVAX Socit Anonyme had not issued any dividends in recent years. Assuming the 90 days horizon the next anticipated press release will be in 5 to 10 days. Check out ABIVAX Société Basic Forecasting Models to cross-verify your projections.ABIVAX Société Related Hype Analysis
Having access to credible news sources related to ABIVAX Société's direct competition is more important than ever and may enhance your ability to predict ABIVAX Société's future price movements. Getting to know how ABIVAX Société's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ABIVAX Société may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
APTCF | Advanced Proteome Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
OXBOF | Oxford BioDynamics Plc | 0.00 | 0 per month | 0.00 | (0.18) | 0.00 | 0.00 | 66.38 | |
GTHR | GeneThera | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
CHNXF | ChitogenX | 0.00 | 0 per month | 0.00 | (0.23) | 0.00 | (5.56) | 48.28 | |
GMDA | Gamida Cell | (0.03) | 29 per month | 0.00 | (0.04) | 6.81 | (7.28) | 28.30 | |
NWBO | Northwest Biotherapeutics | 0.00 | 0 per month | 0.00 | (0.05) | 6.45 | (3.85) | 22.79 | |
CTIC | CTi Biopharma Corp | 0.02 | 8 per month | 0.91 | 0.13 | 5.30 | (3.58) | 85.60 | |
GERN | Geron | (0.13) | 11 per month | 0.00 | (0.12) | 4.12 | (4.13) | 14.00 | |
MDGEF | Medigene AG | 0.00 | 0 per month | 0.00 | 0.06 | 0.00 | 0.00 | 99.23 |
ABIVAX Société Additional Predictive Modules
Most predictive techniques to examine ABIVAX price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ABIVAX using various technical indicators. When you analyze ABIVAX charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About ABIVAX Société Predictive Indicators
The successful prediction of ABIVAX Société stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ABIVAX Socit Anonyme, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ABIVAX Société based on analysis of ABIVAX Société hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ABIVAX Société's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ABIVAX Société's related companies.
Story Coverage note for ABIVAX Société
The number of cover stories for ABIVAX Société depends on current market conditions and ABIVAX Société's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ABIVAX Société is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ABIVAX Société's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
ABIVAX Société Short Properties
ABIVAX Société's future price predictability will typically decrease when ABIVAX Société's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ABIVAX Socit Anonyme often depends not only on the future outlook of the potential ABIVAX Société's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ABIVAX Société's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 16.8 M |
Complementary Tools for ABIVAX Pink Sheet analysis
When running ABIVAX Société's price analysis, check to measure ABIVAX Société's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABIVAX Société is operating at the current time. Most of ABIVAX Société's value examination focuses on studying past and present price action to predict the probability of ABIVAX Société's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABIVAX Société's price. Additionally, you may evaluate how the addition of ABIVAX Société to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |